What is the recommended treatment for a genital herpes flare-up?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Genital Herpes Flare-Up

For a genital herpes flare-up (recurrent episode), the recommended treatment is valacyclovir 500 mg twice daily for 3 days, initiated at the first sign or symptom of an episode. 1

First-Line Antiviral Options

The CDC recommends the following antiviral medications for treating recurrent genital herpes episodes:

  • Valacyclovir: 500 mg twice daily for 5-10 days 2
    • FDA-approved 3-day regimen: 500 mg twice daily 1
  • Famciclovir: 125 mg twice daily for 5 days 2
  • Acyclovir: 400 mg three times daily for 5-10 days 2

Valacyclovir's 3-day regimen has been shown to be as effective as the 5-day course for recurrent episodes, with median time to lesion healing of 4.4 days versus 4.7 days, respectively 3. The shorter course may improve treatment adherence.

Treatment Timing and Efficacy

  • Initiate treatment at the earliest sign or symptom (tingling, itching, or burning) 1
  • Treatment is most effective when started within 24 hours of symptom onset 1
  • Antiviral therapy reduces:
    • Duration of lesions
    • Pain duration
    • Viral shedding
    • Risk of transmission

Dosing Considerations

  • For patients with normal renal function: Standard dosing as above
  • For patients with frequent recurrences (≥10 per year): Consider suppressive therapy with valacyclovir 1 gram once daily 1, 4
  • For patients with fewer recurrences (<10 per year): Valacyclovir 500 mg once daily is effective for suppression 4

Special Populations

  • HIV-infected patients:

    • May require longer courses of therapy
    • For suppressive therapy: Valacyclovir 500 mg twice daily 2
    • More aggressive suppressive therapy may be required due to frequent recurrences 2
  • Pregnant patients:

    • Acyclovir has an established safety profile during pregnancy 2
    • Consider suppressive therapy starting at 36 weeks gestation to reduce risk of outbreak during delivery 5

Preventing Transmission

  • Avoid direct contact with active lesions 2
  • Use latex condoms during sexual activity 2
  • Consider daily suppressive antiviral therapy for those with frequent recurrences 2
  • Avoid sexual contact during outbreaks 5

Common Pitfalls to Avoid

  1. Delayed treatment initiation: Starting therapy more than 24-48 hours after symptom onset significantly reduces effectiveness

  2. Inadequate pain management: For painful lesions, consider adding acetaminophen or NSAIDs 2

  3. Failure to recognize treatment-resistant cases: If lesions persist despite appropriate therapy, consider:

    • Medication adherence issues
    • Potential acyclovir resistance (especially in immunocompromised patients)
    • Alternative diagnoses
  4. Not addressing psychological impact: Genital herpes can cause significant psychological distress that may require additional support

Follow-up Recommendations

  • Re-examine 3-7 days after treatment initiation to assess response 2
  • Monitor for complete resolution of lesions 2
  • Evaluate for potential complications 2

Valacyclovir's once or twice daily dosing makes it an attractive option compared to acyclovir's five-times-daily regimen, potentially improving treatment adherence 6.

References

Guideline

Management of Uncomplicated Herpes Zoster

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Valacyclovir for episodic treatment of genital herpes: a shorter 3-day treatment course compared with 5-day treatment.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002

Research

Genital Herpes: Rapid Evidence Review.

American family physician, 2024

Research

Valacyclovir for the treatment of genital herpes.

Expert review of anti-infective therapy, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.